investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Targeting to Epigenetic Modications in ALL
Scott A Armstrong
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Scott A Armstrong
Memorial Sloan Kettering Cancer Center
New York, United States
Related projects
Dan Landau
The role of epigenetic heterogeneity in CLL evolution
Leukaemia
Scott W Lowe
The impact of chromosome 17p lesions on leukemogeneis and therapy response
Leukaemia
Pathology
Hematology and hematologic malignancies
Alan Rein
Interactions of APOBEC3 Proteins with Murine Leukemia Viruses
Leukaemia
Pathology
Hematology and hematologic malignancies
Peter Aplan
Collaborative Pathways that Lead to Leukemia
Leukaemia
Pathology
Hematology and hematologic malignancies
Kapil Bhalla
Novel Targeted Therapy for AML
Leukaemia
Kenneth Lynn Wright
Natural Killer Cell Regulation by PRDM1 and IRF4/8
Leukaemia
Benjamin Levine Ebert
Development of Novel Therapeutic Strategies in Human Leukemias
Leukaemia
Alan Rein
Retrovirus Assembly And Maturation
Leukaemia
Pathology
Hematology and hematologic malignancies
Harlan S. Robins
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leukemia
Leukaemia